Approval · Notice of Compliance 27463 · 2022
ILUMYA: Notice of Compliance 27463
Issued January 24, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27463
- Date
- January 24, 2022
- Company
- Sun Pharmaceutical Industries LimitedMumbai, Maharashtra, India
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative ¿ Merger / Buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ILUMYA | 02516098 | Marketed |
Medicinal ingredients
- TILDRAKIZUMAB 100 MG per ML